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ABSTRACT We have studied the inhibition of the contraction of glycerinated rabbit psoas muscle caused by ligands that
bind to the ATPase site of myosin. Two ligands, adenosine 5' (13, y-imido) triphosphate (AMPPNP) and pyrophosphate
(PPi), decreased the force and stiffness developed in isometric contractions and the velocity of shortening of isotonic
contractions. The force exerted by isometric fibers was measured as a function of MgATP in the presence and absence
of a constant concentration of the ligands. As the MgATP concentration decreased, the inhibition of tension caused by
the ligand increased, reaching -50% at 25 IuM MgATP and either 2 mM MgPPi or 2 mM MgAMPPNP. The
maximum velocity of shortening was also measured as a function of MgATP concentration in the presence of 1 and 2
mM MgPPi and 2.5 and 5 mM MgAMPPNP. Both ligands acted as pure competitive inhibitors with K, = 3.0 mM for
PP, and 5.1 mM for MgAMPPNP. These data show that both ligands are weak inhibitors of the contraction of fibers.
The results provided information on the energetics of actin-myosin-ligand states that occur in the portion of the
cross-bridge cycle where MgATP binds to myosin. A simple analysis of the inhibition of velocity suggests that
MgAMPPNP binds to the actomyosin complex at this step of the cycle with an effective affinity constant of -2 x 102
M-'.
INTRODUCTION
Muscle contraction is the result of a cyclic interaction
between cross-bridges extending from the myosin fila-
ments and sites on adjacent actin filaments. A myosin
cross-bridge attaches to an actin site, executes a power-
stroke causing a shear displacement between the parallel
filaments, and then detaches to begin a new cycle. Free
energy driving the reaction comes from the hydrolysis of
MgATP. A central question in muscle biophysics is to
understand the process by which this interaction converts
chemical energy into mechanical energy.
The interaction of actin, myosin, and MgATP has been
studied extensively in solution (reviewed by Taylor, 1979;
Eisenberg and Greene, 1980). Myosin hydrolyzes MgATP
rapidly in a cyclic interaction with actin. MgATP that is
bound to the myosin nucleotide site is hydrolyzed primari-
ly, but not exclusively, when the myosin is dissociated from
actin. Myosin, with attached hydrolysis products, then
binds to actin where the products rapidly dissociate. Fol-
lowing product release the binding of MgATP to the
actomyosin complex causes dissociation of myosin from
actin. This last process would be inhibited by ligands that
compete with MgATP for the nucleotide site of myosin.
The general pathways for the actin-myosin-nucleotide
interactions observed in solution are assumed to be similar
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to those found in a functioning muscle (Eisenberg and
Greene, 1980). Problems arise, however, in extrapolating
solution data to the muscle fiber. A major difficulty is
introduced by the geometrical constraints on the actomyo-
sin interaction, which are certainly imposed by the struc-
tural array of actin and myosin filaments in muscle fibers.
The solution studies do not include these constraints. The
rates of many steps observed in solution are altered when
the proteins are incorporated into the filament array where
they are performing mechanical work (reviewed, Sleep and
Smith, 1981). Understanding the differences between solu-
tion studies and the interaction in the fiber has been
difficult because of the problems encountered in measuring
the kinetics of the biochemical interactions occurring in the
fiber.
One approach to measuring the properties of a specified
interaction occurring in the fibers is to observe the contrac-
tion of permeable fibers at different substrate concentra-
tions (Cooke and Bialek, 1979; Cox and Kawai, 1981;
Kawai, 1978; Wilson and White, 1983; Ferenczi et al.,
1984; Chaen et al., 1981; Moss and Haworth, 1984).
Additional data allowing one to link specific kinetic states
with muscle physiology would be of use in understanding
the chemomechanics of contraction. To this end, a
straightforward extension of this approach is to measure
the effect on contraction of ligands that compete for the
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MgATP site of myosin. Two such nonhydrolyzable ligands
are Mg adenosine 5' (,B, y-imido) triphosphate
(MgAMPPNP) and Mg pyrophosphate (MgPPj) (Yount
et al., 1971; Danker, 1983). An extensive body of work has
characterized the interactions of MgAMPPNP with myo-
sin subfragment- 1 (S- I) and acto S- I in solution (Yount et
al., 1971; Konrad and Goody, 1983; Trybus and Taylor,
1982; Greene and Eisenberg, 1980). These data are not
compatible with a simple scheme for the binding of
MgAMPPNP to actomyosin. The association constant of
MgAMPPNP for the protein complex is stronger than
expected from the rates of association and dissociation, and
the rate of dissociation of the ternary complex by low
concentrations of MgATP is about two orders of magni-
tude less than calculated from other known constants.
Binding of MgAMPPNP to rigor fibers results in an
apparent lengthening of the fiber that is probably due to
cross-bridge conformations different from the rigor com-
plex (Marston et al., 1979; Marston, 1980). This effect is
reversible with transition back to the rigor complex cou-
pled to work production (Kuhn, 1981; Kuhn, 1978b). The
energetics of the interaction of MgPPi with S-I and acto
S- I in solution have also been characterized, although little
is known about the kinetics of this interaction (Greene and
Eisenberg, 1980; Danker, 1983). Binding of MgPPi to rigor
fibers results in a force decrease similar to that observed
with MgAMPPNP (White, 1970).
To further understand the relationship between acto S- I
states in solution and those in the fiber we have measured
the effect of two ligands MgAMPPNP and MgPPi on
isometric and isotonic contractions of permeable muscle
fibers as a function of MgATP concentration at varying
MgAMPPNP and MgPPi concentrations. Both ligands
inhibit isometric tension as well as Vmax, the velocity of
contraction at zero force.
A/D boards (Tekmar Co., Cincinnati, OH). For isotonic contractions the
tension of the fiber was compared with a reference tension by the
computer, and a signal to either lengthen or shorten the fiber was sent to
the motor. This feed back loop operated at a frequency of I kHz.
All experiments were performed with a basic rigor buffer bathing the
fibers containing 0.15 M KCI, 5 mM MgCl2, 2 mM EGTA, 1.9 mM
CaC12, 20 mM TES, 20 mM creatine phosphate (CP), and 30-90 ,M
(2.5-7.5 mg/ml) creatine kinase (CK), pH 7.0, pCa -5. The tempera-
ture was regulated at 10 ± 0.20C. In all force-velocity experiments, the
MgCl2 concentration was adjusted to maintain a free Mg++ concentra-
tion of 5 mM using standard binding constants for Mg"+ to ATP,
AMPPNP, and PPi of 1.2 x 104M-', 3.8 x 104M-', and 2.8 x 105M-',
respectively (Smith and Martell, 1975; Yount et al., 1971). Ionic strength
was maintained constant by decreasing the KCI concentration. A creatine
kinase-creatine phosphate feeder system was used in all experiments to
maintain the level of MgATP inside contracting fibers. CK was
purchased from Sigma Chemical Co. (St. Louis, MO) or was prepared by
the method of Kuby (Kuby et al., 1954). As MgAMPPNP and MgPP,
inhibit CK (Nihei et al., 1961; Watts, 1973), the concentration of CK
added to the contraction buffer was adjusted with ligand concentration
(up to 90 gM CK) to insure adequate ATP perfusion of contracting
fibers. AMPPNP was purchased from Sigma Chemical Co. Commer-
cially available AMPPNP is contaminated with small amounts of ATP
and ADP (which is converted to ATP by CK-CP) (Penningroth et al.,
1980). Using a luciferin-luciferase assay (Sigma Chemical Co.) we
determined that 0.6% of total nucleotide in our sample of AMPPNP was
ATP or ADP. Samples of MgAMPPNP were incubated with CK and CP
and the amount of MgATP was assayed by measuring light output
generated by luciferin-luciferase according to the instructions supplied by
Sigma Chemical Co. AMPPNP ran as a single species when chromato-
graphed on thin-layer polyethelyeneimine in the presence of 1 M LiCl, pH
9.0. In the analysis of all experiments involving added MgAMPPNP, the
concentrations of MgATP and MgAMPPNP were adjusted to account
for the 0.6% MgATP contamination.
Force velocity data were analyzed using a variation of the Hill equation
(Hill, 1938). Let
(a + P)V-= (PO - P)b, (1)
where V equals the velocity, P0 equals the isometric force, P equals the
contraction force at velocity V, and a, b are parameters. At P - 0,
V. = bP0/a and setting a = a/PO, the equation can easily be rewritten
V = a Vmax (1 - P/P.) (a + P/P.). (2)
METHODS
Thin bundles of rabbit psoas fibers 1-2 mm diameter were dissected and
tied to thin rods with surgical thread. The bundles were incubated in 50%
glycerol, 50% 0.15 M KCL, 5 mM MgCl2, 10 mM EGTA, and 20 mM
2-[Tris(hydroxymethyl)methylamino]-l-ethanesulfonic acid (TES), pH
7.0 (vol/vol). After 24 h at 0°C the solution was changed and the fibers
were stored at - 200C until used. Storage lasted typically from 2 wk to 2
mo and did not appear to affect mechanical properties.
For mechanical measurements single fibers were dissected on a cold
stage and mounted between the two arms of the tensiometer using perspex
dissolved in acetone as a glue. The length of the mounted fiber was 1 cm.
Sarcomere lengths were determined by diffraction. Initial sarcomere
lengths varied from 2.3 to 2.5 um. Two tensiometers, which gave
comparable results, were used during the course of the study. Earlier
measurements were made using a moving coil to measure fiber tension
and to apply isometric contractions as described by Cooke and Bialek
(1979). Later measurements were made using the tensiometer described
by Crowder and Cooke (1983). The muscle was mounted between a
solid-state force transducer (Akers, 801; Aksjelskapet Microelectronikk,
Horten, Norway) and a light, stiff bereylium arm connected to a rapid
motor (General Scanning, Inc., Watertown, MA) for changing muscle
length. The frequency response for the transducer with fiber loaded was 2
kHz. Tension was monitored by a Compupro Computer using Tekmar
Data analysis is simplified by use of the form in Eq. 2. At each MgATP
and competing ligand concentration, a minimum of 24 force-velocity data
points from a minimum of 6 fibers were used. The two parameters, V,,,,
and a, were determined by a nonlinear least-squares fit of the individual
data points to Eq. 2 using a Gauss-Newton-type interation. A grid search
for starting values of a and Vm,. was used in an attempt to insure the
global minimum sum of the squared residuals. All data points were
weighted equally. Numerical calculations were performed using an
Amdahl 470V/8 computer (Amdahl Corp., Sunnyvale, CA). The com-
puter code used routines from Statistical Analysis Systems Institute
(release 82.3), Carey, NC. Straight lines in Fig. 5 are least-squares linear
approximations to the fitted values of V,. with error bars representing
95% confidence limits from the hyperbolic fit. Means and standard
deviations shown in Fig. 4 were determined by grouping the individual
force-velocity data points into five bins and averaging within each bin in
both the force and velocity directions (Cooke and Bialek, 1979). Least-
squares hyperbolic fits to the isometric tension data in Fig. 2 were
obtained in a fashion similar to that described above.
RESULTS
As expected, the ligands MgPPi and MgAMPPNP inhibit
the contraction of glycerinated rabbit psoas fibers. Single
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fibers were mounted between a force transducer and a fast
motor, which could alter fiber lengths. Force was recorded
as a function of time. The fiber was bathed in a solution
containing the ligand and a variable concentration of
MgATP. The concentration of MgATP inside the fiber
was maintained using a CK-CP regeneration system. It
was found that high levels of either ligand inhibited CK. To
adjust for this, the maximum velocity of contraction was
measured as a function of the CK concentration at 25 ,tM
MgATP and the desired ligand concentration. As the
concentration of CK increased in the absence of ligand the
velocity of contractions also increased, reaching a plateau
at -20 ,IM CK. A similar result was obtained by Cooke
and Bialek (1979). However, 60 ,uM CK was required to
reach the plateau in the presence of either 5 mM
MgAMPPNP or 2 mM MgPPi. Accordingly the concen-
tration of CK was 30 ,uM in experiments run in the absence
of ligands, 90 AM at high ligand concentrations and 60 ,uM
at intermediate ligand concentrations. CP was constant, 20
mM, at all ligand concentrations.
Fig. 1 A shows a typical time course for tension develop-
ment. Tension rose rapidly to a maximum and then
decreased by 10-20% to a level that remained relatively
stable. Measurements of isotonic contractions were made
during the period of steady tension. The time course of
tension development was similar for all fiber preparations.
One or two series of isotonic load clamps were imposed on
the muscle. A series consisted of up to four load clamps as
shown in Fig. 1 B and 2. The experimental protocol used
for measuring the effect of the ligand on isometric tension
was different from that used to measure the effect on
isotonic contraction velocity. Due to the difficulty in
accurately measuring the fiber diameters, the effect of
ligands on fiber tension was determined by comparing the
tensions measured before and after the addition of the
ligand to the medium that was bathing a contracting fiber.
The fiber was mounted on a tensiometer and first
immersed in the basic rigor buffer containing a given
concentration of MgATP. After the tension had stabilized,
ligand was added to the medium and the tension fell to a
new steady state value within - 15 s. The absolute magni-
tude of fiber tension as a function of MgATP concentra-
tion in the absence of ligand was not statistically different
from that presented previously (Cooke and Bialek, 1979),
i.e., in the absence of ligand isometric tension increased as
the MgATP concentration decreased reaching a maximum
at =25-50 ,uM MgATP and then decreasing with increas-
ing ATP concentration.
Fig. 3 A and B give the ratio of fiber force in the
presence of competing ligand to force in the absence of
ligand as a function of MgATP concentration. At high
MgATP concentrations, the ligands had no effect on fiber
tension. As the MgATP concentration decreased, the
inhibition by the ligands increased, as expected for compet-
itive inhibition. When the results of Figs. 3 A and B are
plotted in double reciprocal fashion, i.e., the inverse of
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FIGURE 1 (A) Time course of isometric tension development in a single
contracting glycerinated psoas muscle fiber for 100 ,sM MgATP and no
competing ligand. Deviations at 30 to 60 s following activation represent
four isotonic releases for measurements of contraction velocity. Force
drops at the end when the fiber is broken and a check is made to insure
that there has been no drift in the base line of the force transducer. (B)
Time course of tension during the load clamps shown with an expanded
time scale. The sharp downward deflection is the load clamp, and the
following upward deflection is the rise in tension that occurs when the
fiber is reextended. Data from a similar series of load clamps is shown in
more detail in Fig. 2.
fractional force vs. the inverse of MgATP concentration,
the data did not fit a straight line but displayed a concave
downard curvature as shown in Fig. 3 C. The curvature
seen in Fig. 3 C shows that force is not a simple hyperbolic
function of the MgATP concentration. However, the data
of Figs. 3 A and B could be fit by a hyperbolic function if
one assumes that force extrapolates to a nonzero value
when the MgATP concentration equals zero. This fit is
shown in Figs. 3 A and B and discussed in the next
section.
The velocity of fiber contraction during load clamps
showed a slight decline with time in a manner that was
similar to the decline in tension. The most reproducible
measurements of contraction velocity were obtained by
immersing the fiber in a contracting solution that con-
tained the desired levels of both MgATP and ligand. One
or two series of up to four load clamps were then applied to
the fiber at precise intervals, usually 30 s following the
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FIGURE 2 Original record showing displacement and tension for four
isotonic releases. When the tension reached an approximate steady state,
four isotonic releases were performed to: 0.8 P., 0.6 P., 0.35 P., and 0.12
P.. Following each release the fiber was extended to its original length (1
cm) at a constant velocity of 1 mm/s. After the extensions the fiber was
held isometric for 2 s to allow the tension to return to its original value,
and the next release was then performed. Up to two sets of up to four
releases were performed on each fiber. Left: Decrease in fiber length as a
function of time for isotonic releases at four different forces. Straight lines
represent least-squares linear fits to data; slopes give velocities of contrac-
tion. Right: Force (P) divided by the isometric tension at the beginning of
the series (PO) as a function of time for contractions shown on the left. The
traces with greater slopes shown on the left correspond to releases to lower
tensions shown on the right. The MgATP concentration was 50 AM.
activation of the fiber. The fiber length and fiber tension
recorded during one series of four isometric releases are
shown in Fig. 2. The length of the fiber first decreased
rapidly due to series elasticity of the fiber following the
release to a new tension. The length then showed a linear
decrease with time. The linear portion of the length vs.
time trace between 10 and 40 s was fitted to a straight line
by linear regression. The slope of this line gives the velocity
of contraction. This portion of the length-time trace was
approximately linear for all of the experimental conditions
that were studied. The tensions were also averaged over the
same time period to determine the mean fiber tension
during the releases. Release tension was varied between
0.05 and 0.95 times PO to construct complete force velocity
curves shown in Fig. 4. Isotonic velocities of contraction
measured during the series of four releases shown in Fig. 2
were similar to those in which only one isotonic release was
performed during the activation. The effect of the previous
fiber history on the data was examined by measuring
velocity attained in a load clamp to 0.3 PO as a function of
the time at which the load clamp was applied. In a series of
four load clamps the velocity measured in the first and
fourth release did not differ by more than 5%. Although
the velocity measured decreased by -10% over the first
2-3 min of the contraction, this decrease appeared to be
similar in all fibers and was not influenced by isotonic
releases.
The ligands inhibited the velocity of contraction to
approximately the same degree that they inhibited the
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FIGURE 3 The relative isometric force of single glycerinated psoas
muscle fibers shown as a function of the MgATP concentration in the
presence of MgAMPPNP and MgPPi. At each MgATP concentration,
forces represent the ratio of force in the presence of competing ligand to
force in the absence of competing ligand. The absolute magnitude of the
isometric tension rises by -50% as the ATP concentration is lowered from
1 mM to 25MgM as shown by Cooke and Bialek (1979). (A) 1 mM (o) and
0.35 mM (e) MgAMPPNP. (B) 2 mM (o) and 0.5 mM (e) MgPP,. The
medium contained the nucleotides in rigor buffer plus 1.8 mM CaC12, 20
mM CP, and variable amounts of CK, 30-90 IAM, as described in
Methods. Each data point represents the mean of six different measure-
ments. The solid lines are least-squares hyperbolic fits to the data as
described in the text. (C) The data of A and B, above, are replotted in a
double reciprocal fashion. 1 mM (o) and 0.35 mM (A) MgAMPPNP, 2
mM (*) and 0.5 mM MgPP, (O).
tension. Fig. 4 shows force-velocity relations recorded in
the presence and absence of 5 mM MgAMPPNP. The
maximum velocities of contraction were obtained by fitting
the data to Eq. 2, shown by the solid lines in Fig. 4, and
extrapolating to zero tension. The maximum velocity was
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FIGURE 4 The velocity of contraction of single muscle fibers is shown as
a function of the relative force exerted by the fibers. The contraction
medium contained 25 MM MgATP (A), 31 ,uM MgATP, and 5 mM
MgAMPPNP (A), 100 ,M MgATP (e), 100 MM MgATP, and 5 mM
MgAMPPNP (o). The dashed line is the force-velocity relation at
saturating MgATP concentrations, 5 mM (Cooke and Bialek, 1979). The
medium also contained 20 mM CP and 30-90,uM CK. The solid lines are
Hill's equation, Eq. 2, fit to the data by a nonlinear, least-squares method.
Means and standard deviations are from between 4 and 14 (average = 9)
distinct force-velocity measurements as described in Methods.
recorded as a function of MgATP concentration for two
different ligand concentrations and the results plotted in
double reciprocal fashion, see Fig. 5. The inhibition of the
contraction velocity by MgPPi was very similar to that
observed for MgAMPPNP; 2 mM MgPPi producing
approximately the same effect as 5 mM MgAMPPNP. In
both the absence and presence of the ligands, all of the data
on the inhibition of contraction velocity can be fit within
experimental accuracy by the equations derived to explain
the competitive inhibition of a simple enzymatic reaction
obeying Michaelis-Menten kinetics: V = Vmax (ATP)/ [Km
(1 + Ci/K ) + ATP], where Vmax is the maximum
contraction velocity at infinite MgATP concentration, Km
is the Michaelis constant that describes the dependence of
velocity upon MgATP concentration, C, is the concentra-
tion of ligand, and Ki is its inhibition constant. This
equation predicts that plots of the inverse of the velocity vs.
the inverse of the substrate concentration should be
straight lines as is observed in the data shown in Fig. 5. The
value of Ki can be determined from the intercept on the
abscissa. For MgAMPPNP the two intercepts provide
values for Ki of 5.0 mM (2.5 mM MgAMPPNP) and 5.2
mM (5 mM MgAMPPNP). The corresponding values of
K, for MgPPi are 2.9 mM (1 mM MgPPj) and 3.1 mM (2
mM MgPPi). the fact that the values of Kj determined at
two different concentrations of ligand agree within experi-
mental error provides additional support for the observa-
tion that both ligands appear to act as pure competitive
inhibitors of the maximum velocity of contraction. Averag-
ing the data at the two ligand concentrations, we obtain a
Kj of 3.0 mM for MgPPi and a Ki of 5.1 mM for
MgAMPPNP.
DISCUSSION
The ligands, MgAMPPNP and MgPPi, are not hydrolyz-
able by actomyosin and complete with MgATP for the
active site slowing the overall cross-bridge turnover rate
through the actomyosin ATPase cycle (Yount et al., 1971;
Marston et al., 1976). Because the binding of MgATP in
the cycle dissociates the actomyosin bond, competition by
the ligands should slow the rate of dissociation. During
isotonic contractions, undissociated myosin heads must be
detached mechanically as the actin filament continues to
move; this will slow the velocity of contraction. Thus,
qualitatively the observed inhibition of velocity by the
ligands is in accord with current models of cross-bridge
function. A similar decrease in velocity has been observed
as the concentration of MgATP is lowered. Although the
tension of a fiber is the result of enzymatic activity, it does
not follow classical behavior. For instance, as the substrate
concentration decreases the tension at first increases and
then decreases (Cooke and Bialek, 1979; Chaen et al.,
1981; Ferenczi et al., 1984). One explanation for the
behavior of isometric tension as substrate or ligand concen-
trations vary is that actomyosin states can exert tension
when the nucelotide site of myosin is either filled with
ligand or is empty as has been suggested by studies on rigor
fibers (Marston et al., 1979; Kuhn, 1978a). Assuming that
ligand-bound states can exert force, one might expect the
data of Figs. 3 A and B to fit a hyperbola with a nonzero
intercept on the force axis as substrate approaches zero.
The data of Figs. 3 A and B do in fact fit such a curve, as
shown by the solid lines. With all units in micromoles and x
representing the concentration of MgATP, the hyperbolae
in Fig. 3 A are given by (x + 13.7)/(x - 17.7) for 0.35
mM MgAMPPNP, (x + 7.8)/(x + 18.7) for 2 mM
MgAMPPNP. The hyperbolae define a Michaelis con-
stant, Km, for MgATP of 3 ,uM and an inhibition constant,
K,, for MgAMPPNP of 1 mM. The inhibition of isometric
tension by MgPPi was similar to that observed for
MgAMPPNP. These data, shown in Fig. 3 B could also be
fitted with hyperbolae with nonzero intercepts. For 0.5
mM MgPP; the hyperbola is given by (x + 8.8)/(x +
17.1) and for 2 mM MgPPi by (x + 7.8)/(x + 21.3). The
fits define a similar Km for MgATP of 6 ,AM, and a Ki of 2
mM.
The cyclic actomyosin-nucleotide interaction that pro-
duces force and movement in the fibers is obviously
complex, and it is thus rather surprising that experimen-
tally both ligands appear to be pure competitive inhibitors
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FIGURE 5 The inverse of the velocity of contraction is shown as a function of the inverse of the MgATP concentration for (A) MgAMPPNP
concentrations: 0 mM, (-); 2.5 mM, (A); and 5 mM, (Cl), and for (B) pyrophosphate concentrations: 0 mM (e), 1 mM (A), 2 mM (O). The
straight, solid lines are least-squares linear regression fits to the data. Each value of V.,n is determined from a nonlinear fit of between 24 and
62 (average = 36) force-velocity measurements as described in Methods. Error bars represent 95% confidence limits.
of the maximum velocity and contraction. It is in fact
equally surprising that the dependence of the velocity of
contraction on MgATP concentration also follows Michae-
lis-Menten kinetics. Both the data of Cooke and Bialek
(1979) and that obtained here can be described by this
formalism with Michaelis constant, Ki,m of 0.25 mM and a
Vmax of 2.1 1/s. Ferenczi et al. (1979) using frog muscle
found an approximate fit to Michaelis-Menten kinetics
with a Km of 0.47 mM, and values of 0.2-0.8 mM have
been obtained by Kawai (1982) and by Shimizu and
Tanaka (1984) for the Km associated with the response to
sinusoidal oscillation. Note that very similar results are
obtained in another motile system. The beat frequency of
sea urchin sperm flagella decreases as the MgATP concen-
tration is lowered, following Michaelis-Menten type kinet-
ics with Km = 0.22 mM (Brokaw, 1975). The beat
frequency is also competitively inhibited by MgAMPPNP
with a Ki of 3.1 mM (Okuno and Brokaw, 1981). The
kinetics followed by both substrate and MgAMPPNP as
well as the values obtained for Km and Ki are very similar to
the results obtained here. This suggests that basic similari-
ties between the mechanisms of force production in the two
systems may exist.
In the case of classical competitive inhibition of enzy-
matic activity, Ki is equal to the dissociation constant of the
ligand from the enzyme site. However, in the case of the
inhibition of contraction velocity the connection between
the strength of ligand binding and the observed inhibition
depends on a number of aspects of the cross-bridge cycle.
Although a rigorous discussion of this question requires
consideration of a rather complicated model of cross-
bridge kinetics, some simple arguments can suggest a
connection between the affinity of ligand binding and the
inhibition of contraction velocity. We assume that MgATP
competes with the ligand at one point in the cross-bridge
cycle. This region of competition is most probably a small
portion of the powerstroke, and we initially assume it
occurs over a region of length 2 nm. However the argu-
ments presented below do not depend strongly on the exact
value. IfMgAMPPNP binds to a myosin site in this region,
then the myosin is dissociated mechanically and will rebind
to actin where it again enters the region of nucleotide
competition. This assumption can be changed and we
consider alternative models following the discussion below.
Within the framework of these assumptions we now ask
whether the observed inhibition of fiber contraction veloc-
ity can be explained if nucelotides bind to the cross-bridge
in this region with the same affinities and rates as to
actomyosin subfragment- 1 in solution. We consider con-
traction at 25 AM MgATP in the presence and absence of 5
mM MgAMPPNP. At 25 ,tM MgATP the velocity of
contraction is experimentally observed to be ten times
slower than at saturating MgATP, so that a considerable
fraction of nucleotide free A . M states should be available
for ligand binding (here A signifies actin and M signifies
either myosin or myosin subfragments). The fractions of
cross-bridges that bind MgATP or MgAMPPNP are
estimated from their relative rates of binding to A * M in
solution. MgATP binds to the A * M state with a rate of
-2 x 106 M-'s- (Taylor, 1979; Goldman et al., 1984;
Kawai, 1982) or at 25 ,M MgATP, with an effective rate
constant of 50 s-'. In the absence of MgAMPPNP and at
25 ,uM MgATP, approximately one-half of the myosin
heads are detached by MgATP at the experimentally
observed Vmax of 0.2 lengths/s. The corresponding rate for
MgAMPPNP is 1.2 x 104 M-'s-' (Trybus and Taylor,
1982) or at 5 mM MgAMPPNP with an effective rate
constant of 60 s-'. Thus whenever an A - M bridge
becomes available, MgATP and MgAMPPNP compete
almost equally for the myosin nucleotide site. At first this
BIOPHYSICAL JOURNAL VOLUME 47 1985778
may seem compatible with an observed twofold inhibition
of fiber velocity under these conditions. However, one has
to consider the fate of the MgAMPPNP bound to the
myosin. If MgAMPPNP is not dissociated from the myo-
sin in another step of the cycle, then the M * AMPPNP
complex will be detached from actin mechanically and will
rebind to actin returning to the region where MgATP and
ligand again compete for the myosin site. Assuming that
the affinity constant of 104 M' for binding of
MgAMPPNP to A . M measured by equilibrium methods
(Greene and Eisenberg, 1980; Konrad and Goody, 1982)
applies at the end of the powerstroke, the rate at which
MgAMPPNP dissociates from the A . M * AMPPNP
state can be defined. The above model can be easily
analyzed to provide the concentrations of the three states
within the region of nucleotide binding as a function of
position and fiber velocity. MgAMPPNP competes very
effectively with MgATP and almost all of the myosin
heads (97%) bind to MgAMPPNP. This would cause a
dramatic decrease in the contraction velocity. The correct
decrease in velocity is predicted if one assumes that the
affinity constant of MgAMPPNP for the A * M state is 2
x 102 M-'. With this affinity the rate of MgATP binding
is effectively decreased by a factor of two and approxi-
mately one-half of the myosin heads bind MgATP and are
dissociated at the measured Vmax of 0.1 lengths/s. An
alternative analysis is to determine the rate of
MgAMPPNP release from A . M from the data of Kon-
rad and Goody (1982). In the presence of MgATP, the
A . M * AMPPNP complex is dissociated at a rate of 1.9
x 104 M-'s-'. At 25 ,M ATP, this yields an effective rate
constant of 0.5 s-'. At 5 mM AMPPNP, the maximum
contraction velocity is 0.1 lengths/s and a cross-bridge
traverses the 2-nm region of ligand competition in -0.02 s.
Thus with a rate constant of 0.5 s-', only 1% of the
A . M * AMPPNP states are dissociated as a cross-bridge
crosses the region of nucleotide competition. Once bound,
MgAMPPNP is very difficult to remove given the rate of
MgATP binding to A . M * AMPPNP measured in solu-
tion, again suggesting a substantially greater inhibition of
Vmax than observed. If the region of competition is extended
to 10 nm, the cross-bridge remains in it for five times
longer, and the only result is that now 5% of the
A . M * AMPPNP states can be dissociated by ATP in a
single pass.
Within the framework of the assumptions presented
above, we reach the conclusion that the observed inhibition
of velocity implies that the affinity of MgAMPPNP for
actomyosin must be more than an order of magnitude
weaker than its affinity measured by equilibrium methods
in solution or in rigor fibers. Note that the affinity of
MgAMPPNP for acto S- 1 measured by the dependence of
the rate of acto S-1 dissociation by MgAMPPNP has
about the same magnitude as that required to explain the
inhibition of velocity (Konrad and Goody, 1982; Trybus
and Taylor, 1982).
Our estimation of the ligand affinity is reached under
the assumption that MgATP and ligand compete at one
step of the cycle and that bound ligands are not dissociated
at other steps in the cycle. The model is not unique and
other schemes can explain the data. Specifically if
MgAMPPNP is dissociated from A- M at some other
step in the cycle, then the twofold inhibition observed at 25
zM MgATP and 5 mM MgAMPPNP is expected,
because their relative rates of binding to A- M are
approximately equivalent.
In the above analysis, we considered the ligand
MgAMPPNP because more data are available on its
interaction with the contractile proteins. However, in many
respects MgPPi and MgAMPPNP are equivalent: their
affinities for A - M in solution, and their Ki's for the
inhibition of tension or contraction velocity are similar.
Thus the discussion of MgAMPPNP may well apply to
MgPPi. Additional data on the kinetics of the interaction of
MgPPi with actin and myosin would be required to resolve
this question precisely.
The affinity of MgAMPPNP for acto S-I measured by
equilibrium methods in solution would detect the affinity
of the acto S- I state that binds MgAMPPNP most tightly.
Our analysis suggests that this state is not the one that
occurs at the end of the powerstroke. If the state with
highest affinity for MgAMPPNP occurs a few nanometers
before the end of the powerstroke, then the binding of
MgAMPPNP to rigor muscle would result in effectively
lengthening the fiber as experimentally observed. Further-
more, with this assumption it is possible to explain the data
obtained with fibers and to resolve ambiguities in the
affinity constant for MgAMPPNP to A - M noted in
solution studies (Trybus and Taylor, 1982; Konrad and
Goody, 1982) within the framework of a single model of
the actomyosin-nucleotide interaction. Details of this
model will be published elsewhere.
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